• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4: Steele John E. converted options into 13,951 shares and covered exercise/tax liability with 4,089 shares, increasing direct ownership by 1% to 759,943 units (for tax liability)

    9/19/22 7:47:07 PM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology
    Get the next $CNVY alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    1. Name and Address of Reporting Person*
    Steele John E.

    (Last) (First) (Middle)
    C/O CONVEY HEALTH SOLUTIONS
    100 SE THIRD AVENUE, 26TH FLOOR

    (Street)
    FT. LAUDERDALE FL 33394

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Convey Health Solutions Holdings, Inc. [ CNVY ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    EVP, Technology
    3. Date of Earliest Transaction (Month/Day/Year)
    06/15/2022
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 06/15/2022 M 11,161 A $0 761,242 D
    Common Stock 06/15/2022 F 3,271 D $3.97(1) 757,971 D
    Common Stock 09/15/2022 M 2,790 A $0 760,761 D
    Common Stock 09/15/2022 F 818 D $10.5(1) 759,943 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Restricted Stock Units (2) 06/15/2022 M 11,161 (2) (2) Common Stock 11,161 $0 33,482 D
    Restricted Stock Units (2) 09/15/2022 M 2,790 (2) (2) Common Stock 2,790 $0 30,692 D
    Explanation of Responses:
    1. Represents the satisfaction of tax withholding obligations upon the vesting of restricted stock units.
    2. Represents vesting of restricted stock units granted on June 15, 2021. The remainder vests in 11 equal installments every three months, subject to Mr. Steele's continued service with the Convey Health Solutions Holding, Inc. (the "Issuer") through the applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Each unit converts into a share of common stock on a one-for-one basis.
    /s/ Giovanni Castellanos, attorney-in-fact for John E. Steele 09/19/2022
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $CNVY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CNVY

    DatePrice TargetRatingAnalyst
    4/7/2022$12.00Buy
    Guggenheim
    2/11/2022$10.00Neutral
    Goldman
    7/12/2021$18.00Buy
    Canaccord Genuity
    7/12/2021$16.00Buy
    Truist Securities
    7/12/2021$21.00Buy
    Goldman
    7/12/2021$15.00Buy
    BofA Securities
    7/12/2021$16.00Overweight
    Barclays
    7/12/2021$12.00Neutral
    JP Morgan
    More analyst ratings

    $CNVY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Steele John E. returned $1,915,148 worth of shares to the company (182,395 units at $10.50), decreasing direct ownership by 97% to 5,775 units

    4 - Convey Health Solutions Holdings, Inc. (0001787640) (Issuer)

    10/12/22 7:34:43 PM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology

    SEC Form 4 filed by Mansukani Sharad

    4 - Convey Health Solutions Holdings, Inc. (0001787640) (Issuer)

    10/12/22 7:33:33 PM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology

    SEC Form 4: Whitmer William Carl returned $264,600 worth of shares to the company (25,200 units at $10.50), closing all direct ownership in the company

    4 - Convey Health Solutions Holdings, Inc. (0001787640) (Issuer)

    10/12/22 7:31:54 PM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology

    $CNVY
    SEC Filings

    View All

    SEC Form 15-12G filed by Convey Health Solutions Holdings Inc.

    15-12G - Convey Health Solutions Holdings, Inc. (0001787640) (Filer)

    10/17/22 5:19:00 PM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology

    SEC Form S-8 POS filed by Convey Health Solutions Holdings Inc.

    S-8 POS - Convey Health Solutions Holdings, Inc. (0001787640) (Filer)

    10/7/22 3:52:23 PM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology

    SEC Form S-8 POS filed by Convey Health Solutions Holdings Inc.

    S-8 POS - Convey Health Solutions Holdings, Inc. (0001787640) (Filer)

    10/7/22 3:51:23 PM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology

    $CNVY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Guggenheim initiated coverage on Convey Health with a new price target

    Guggenheim initiated coverage of Convey Health with a rating of Buy and set a new price target of $12.00

    4/7/22 7:11:01 AM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology

    Goldman initiated coverage on Convey Health with a new price target

    Goldman initiated coverage of Convey Health with a rating of Neutral and set a new price target of $10.00

    2/11/22 7:13:46 AM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology

    Canaccord Genuity initiated coverage on Convey Health with a new price target

    Canaccord Genuity initiated coverage of Convey Health with a rating of Buy and set a new price target of $18.00

    7/12/21 7:50:21 AM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology

    $CNVY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Convey Announces Closing of Acquisition by TPG

    Convey Taken Private by TPG for $10.50 per Share in Cash FORT LAUDERDALE, Fla., Oct. 7, 2022 /PRNewswire/ -- Convey Health Solutions Holdings, Inc. (NYSE:CNVY) ("Convey"), a leading healthcare technology and services company, announced today the closing of its acquisition by TPG Capital, the large-scale U.S. and European private equity platform of alternative asset management firm TPG. On June 21, 2022, Convey announced that TPG Capital had signed a definitive agreement to acquire all of the outstanding shares of Convey common stock not currently owned by TPG or certain manage

    10/7/22 8:30:00 AM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology

    Convey To Be Taken Private By TPG

    Convey Shareholders to Receive $10.50 per Share in Cash, Representing a 99% Premium Over Convey's 30-Day Volume Weighted Average Price FORT LAUDERDALE, Fla., June 21, 2022 /PRNewswire/ -- Convey Health Solutions Holdings, Inc. (NYSE:CNVY) ("Convey"), a leading healthcare technology and services company, announced today that it has entered into a definitive merger agreement pursuant to which TPG Capital, the private equity platform of global alternative asset management firm TPG ("TPG") and Convey's principal shareholder, will acquire all of the outstanding shares of Convey common stock not currently owned by TPG or certain management and director shareholders for $10.50 per share in cash, re

    6/21/22 7:00:00 AM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology

    Convey Health Solutions Announces Financial Results for First Quarter 2022

    First Quarter 2022 Highlights Net revenues of $96.7 million, up 17% compared to Q1 2021 of $82.6 millionNet loss of $1.2 million, which includes $1.6 million of HealthSmart purchase accounting and acquisition related expenses, compared to Q1 2021 net loss of $0.9 millionAdjusted EBITDA of $15.3 million, compared to Q1 2021 of $15.9 millionFORT LAUDERDALE, Fla., May 10, 2022 /PRNewswire/ -- Convey Health Solutions Holdings, Inc. (NYSE:CNVY) (the "Company" or "Convey"), a leading healthcare technology and services company in the U.S., announced today financial results for the first quarter ended March 31, 2022.

    5/10/22 4:05:00 PM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology

    $CNVY
    Leadership Updates

    Live Leadership Updates

    View All

    Convey Health Solutions Holdings, Inc. Appoints Paul V. Campanelli to Board of Directors

    FORT LAUDERDALE, Fla., Feb. 15, 2022 /PRNewswire/ -- Convey Health Solutions Holdings, Inc. (NYSE:CNVY) ("Convey"), a leading healthcare technology and services company, today announced the appointment of Paul Campanelli to its Board of Directors ("Board"). Mr. Campanelli has approximately 30 years of experience in the healthcare industry, including leadership positions in both publicly held and private equity controlled companies. Mr. Campanelli previously served as Chairman of the Board of Endo International ("Endo") from November 2019 to June 2021, and previously served as

    2/15/22 4:05:00 PM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology

    $CNVY
    Financials

    Live finance-specific insights

    View All

    Convey Health Solutions Announces Financial Results for First Quarter 2022

    First Quarter 2022 Highlights Net revenues of $96.7 million, up 17% compared to Q1 2021 of $82.6 millionNet loss of $1.2 million, which includes $1.6 million of HealthSmart purchase accounting and acquisition related expenses, compared to Q1 2021 net loss of $0.9 millionAdjusted EBITDA of $15.3 million, compared to Q1 2021 of $15.9 millionFORT LAUDERDALE, Fla., May 10, 2022 /PRNewswire/ -- Convey Health Solutions Holdings, Inc. (NYSE:CNVY) (the "Company" or "Convey"), a leading healthcare technology and services company in the U.S., announced today financial results for the first quarter ended March 31, 2022.

    5/10/22 4:05:00 PM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology

    Convey Health Solutions to Announce First Quarter 2022 Financial Results on May 10, 2022

    FORT LAUDERDALE, Fla., May 3, 2022 /PRNewswire/ -- Convey Health Solutions Holdings, Inc. (NYSE:CNVY) ("Convey Health Solutions" or "Convey"), a leading healthcare technology and services company, announced today that it will issue a press release with first quarter 2022 financial results on Tuesday, May 10, 2022 after the market closes. In conjunction with the release, Convey will host a conference call to review these financial results at 4:30 p.m. (ET) on the same day. First Quarter 2022 Conference Call Details The conference call can be accessed by dialing (844) 200-6205 for U.S. participants, or +1 (929) 526-1599 for international participants, referencing access code 105506; or via a l

    5/3/22 4:17:00 PM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology

    Convey Health Solutions to Announce Fourth Quarter and Full Year 2021 Financial Results and Issue 2022 Guidance on March 23, 2022

    FORT LAUDERDALE, Fla., Feb. 23, 2022 /PRNewswire/ -- Convey Health Solutions Holdings, Inc. (NYSE:CNVY) ("Convey Health Solutions" or "Convey"), a leading healthcare technology and services company, announced today that it will issue a press release with fourth quarter and full year 2021 financial results and 2022 guidance on Wednesday, March 23, 2022 after the market closes. In conjunction with the release, Convey will host a conference call to review these financial results at 5:00 p.m. (ET) on the same day. Fourth Quarter and Full Year 2021 Conference Call Details The confe

    2/23/22 8:00:00 AM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology

    $CNVY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Convey Health Solutions Holdings Inc. (Amendment)

    SC 13G/A - Convey Health Solutions Holdings, Inc. (0001787640) (Subject)

    2/10/23 4:26:13 PM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology